A detailed history of Dcm Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Dcm Advisors, LLC holds 2,372 shares of ABT stock, worth $244,434. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,372
Previous 4,969 52.26%
Holding current value
$244,434
Previous $546,000 50.73%
% of portfolio
0.11%
Previous 0.2%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $284,423 - $314,133
-2,597 Reduced 52.26%
2,372 $269,000
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $45,726 - $55,972
-507 Reduced 9.26%
4,969 $546,000
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $67,730 - $81,265
-709 Reduced 11.46%
5,476 $530,000
Q2 2023

Sep 12, 2023

BUY
$100.78 - $112.29 $152,278 - $169,670
1,511 Added 32.33%
6,185 $674,000
Q1 2023

Sep 12, 2023

SELL
$96.86 - $114.01 $13,947 - $16,417
-144 Reduced 2.99%
4,674 $473,000
Q4 2022

Sep 08, 2023

SELL
$95.06 - $111.52 $23,479 - $27,545
-247 Reduced 4.88%
4,818 $529,000
Q3 2022

Sep 08, 2023

BUY
$96.76 - $112.03 $68,893 - $79,765
712 Added 16.36%
5,065 $490,000
Q2 2022

Aug 15, 2022

BUY
$102.07 - $123.37 $45,829 - $55,393
449 Added 11.5%
4,353 $473,000
Q1 2022

May 09, 2022

SELL
$114.02 - $139.04 $210,594 - $256,806
-1,847 Reduced 32.12%
3,904 $462,000
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $363,341 - $444,891
3,145 Added 120.68%
5,751 $810,000
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $1,049 - $1,161
9 Added 0.35%
2,606 $308,000
Q2 2021

Aug 10, 2021

SELL
$105.79 - $124.53 $1.58 Million - $1.87 Million
-14,980 Reduced 85.23%
2,597 $301,000
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $1.32 Million - $1.56 Million
12,154 Added 224.12%
17,577 $2.11 Million
Q4 2020

Feb 02, 2021

BUY
$105.0 - $114.42 $569,415 - $620,499
5,423 New
5,423 $594,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $180B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Dcm Advisors, LLC Portfolio

Follow Dcm Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcm Advisors, LLC with notifications on news.